Contrast infusion sonography to assess microinsert placement and tubal occlusion after Essure.

Fertil Steril

Department of Gynecology, Cleveland Clinic Florida, Weston, Florida 33331, USA.

Published: June 2006

Objective: To develop a technique for contrast infusion sonography and assess the possible use in determining microinsert placement and tubal status after Essure sterilization.

Design: Techniques and instrumentation.

Setting: Healthy women in an academic multispecialty group.

Patient(s): Ten women desiring permanent sterilization who have recently undergone Essure hysteroscopic sterilization.

Intervention(s): Contrast infusion sonography, an adaptation of hysterosalpingo contrast sonography, performed at 3-23 weeks after Essure placement.

Main Outcome Measure(s): To determine how readily tubal status and microinsert location could be assessed with this adaptation of hysterosalpingo contrast sonography.

Result(s): All microinserts were readily identified and tubal status was assessed by identification or absence of real-time contrast agent flow.

Conclusion(s): This technique is very promising and could represent a convenient alternative to hysterosalpingogram (HSG) 3 months after Essure placement.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.fertnstert.2005.10.075DOI Listing

Publication Analysis

Top Keywords

contrast infusion
12
infusion sonography
12
tubal status
12
sonography assess
8
microinsert placement
8
placement tubal
8
adaptation hysterosalpingo
8
hysterosalpingo contrast
8
contrast
6
essure
5

Similar Publications

Potassium metal batteries are emerging as a promising high-energy density storage solution, valued for their cost-effectiveness and low electrochemical potential. However, understanding the role of potassiphilic sites in nucleation and growth remains challenging. This study introduces a single-atom iron, coordinated by nitrogen atoms in a 3D hierarchical porous carbon fiber (Fe─N-PCF), which enhances ion and electron transport, improves nucleation and diffusion kinetics, and reduces energy barriers for potassium deposition.

View Article and Find Full Text PDF

Aging Skin: A Dermatitis To Which All Flesh Is Heir?

J Cutan Pathol

January 2025

Program in Dermatopathology, Department of Pathology, Brigham and Women's Hospital/Mass General Brigham, Boston, Massachusetts, USA.

The human body is composed mostly of water fortified by a variety of proteins, fats, carbohydrates, vitamins, minerals, and other nutrients, all organized into an elegant structurally complex and functionally efficient machine in which our consciousness resides. This heterogeneous assemblage of essential ingredients is enclosed in a container known as the integument, or simply, the skin. The container is as important as its contents; when itself devoid of structural and functional integrity, it will both leak as well as become infused with potentially harmful external agents.

View Article and Find Full Text PDF

Purpose: To develop an educational, interactive, ultra-high resolution, in vivo magnetic resonance (MR) neurography atlas for direct visualization of the brachial plexus and upper extremity.

Methods: A total of 16 adult volunteers without known peripheral neuropathy underwent magnetic resonance (MR) neurography of the brachial plexus and upper extremity. To improve vascular suppression, subjects received an intravenous infusion of ferumoxytol.

View Article and Find Full Text PDF

Natural Mutation of PrfA K10N/T151A Enhances Serotype 4h Virulence.

Foodborne Pathog Dis

January 2025

College of Biological Sciences and Technology, Yangzhou University, Yangzhou, China.

PrfA is a key virulence regulator for (Lm) responding to host environment. Here we report that the natural mutation in PrfA enhanced the pathogenicity of hypervirulent serotype 4h . We characterized the phylogenetic tree of PrfA, and found that PrfA prevalently distributed in all serotype 4h isolates.

View Article and Find Full Text PDF

Background: Rare bleeding disorders (RBDs) include fibrinogen (Factor I), prothrombin (Factor II), Factor V(FV), combined Factor V and Factor VIII, Factor VII, Factor X, Factor XI, Factor XII, and Factor XIII deficiencies. This group accounts for 3-5% of all factor deficiencies. Different symptoms may occur, ranging from mild or moderate bleeding to serious and life-threatening bleeding, which may not be related to the factor level.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!